The U.S. Food and Drug Administration (FDA) has announced that Abbott is recalling some of its Proclaim and Infinity neurostimulation systems due to an ongoing issue with patients being unable to exit MRI mode. This is a Class I recall, which means the FDA has determined the use of these devices “may cause serious injuries or death.”
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
